T-MATE Trademark

Trademark Overview

On Monday, June 28, 2021, a trademark application was filed for T-MATE with the United States Patent and Trademark Office. The USPTO has given the T-MATE trademark a serial number of 90799429. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Amberstone Biosciences. The T-MATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services for medical purposes in the field of antibody discovery, immunology, immunotherapeutic discovery, synthetic biology, and assay chemistry; Pharmaceutical research services, namely, developing pharmaceutical preparations derived from monoclonal antibody and immunotherapeutic screening and synthetic biology screening, directly from heterogenous immune cells, hybridoma, and engineered cell expression libraries; Laboratory research related to pharmaceuticals; Providing medical and scientific research information in the field of preclinical and clinical therapies; Consulting services in the field of implementation of scientific research and clinical trials
t-mate

General Information

Serial Number90799429
Word MarkT-MATE
Filing DateMonday, June 28, 2021
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7414243
Registration DateTuesday, June 11, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Goods and ServicesResearch services for medical purposes in the field of antibody discovery, immunology, immunotherapeutic discovery, synthetic biology, and assay chemistry; Pharmaceutical research services, namely, developing pharmaceutical preparations derived from monoclonal antibody and immunotherapeutic screening and synthetic biology screening, directly from heterogenous immune cells, hybridoma, and engineered cell expression libraries; Laboratory research related to pharmaceuticals; Providing medical and scientific research information in the field of preclinical and clinical therapies; Consulting services in the field of implementation of scientific research and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code042
First Use Anywhere DateTuesday, November 30, 2021
First Use In Commerce DateWednesday, November 30, 2022

Trademark Owner History

Party NameAmberstone Biosciences
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653
Party NameAmberstone Biosciences
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653
Party NameAmberstone Biosciences
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Trademark Events

Event DateEvent Description
Thursday, July 1, 2021NEW APPLICATION ENTERED
Friday, September 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022ASSIGNED TO EXAMINER
Friday, March 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 1 FILED
Tuesday, December 13, 2022SOU EXTENSION 1 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, May 26, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, June 21, 2023SOU EXTENSION 2 FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, September 28, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, September 28, 2023PETITION TO REVIVE-GRANTED
Thursday, September 28, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, September 28, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, September 28, 2023NOTICE OF REVIVAL - E-MAILED
Monday, October 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 18, 2023SOU EXTENSION 2 GRANTED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 22, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, December 21, 2023SOU EXTENSION 3 FILED
Friday, December 22, 2023TEAS PETITION TO REVIVE RECEIVED
Friday, December 22, 2023PETITION TO REVIVE-GRANTED
Friday, December 22, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 22, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, January 2, 2024SOU EXTENSION 3 GRANTED
Wednesday, January 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2024USE AMENDMENT FILED
Tuesday, March 19, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, March 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

mate research field services pharmaceutical biology from clinical synthetic scientific screening